Introduction
There is evidence to support specific exercise therapies as a cornerstone in the comprehensive management of chronic fatigue syndrome. [1] [2] [3] The evidence from individual randomized clinical trials is underscored by the conclusions of a systematic literature review by the Cochrane Collaboration. 4 However, too vigorous exercise [5] [6] [7] or a 30% increase in activity 8 frequently triggers post-exertional malaise in people with chronic fatigue syndrome, a primary characteristic evident in up to 95% of people with chronic fatigue syndrome. 9 The severe exacerbation of symptoms following exercise, as seen in chronic fatigue syndrome patients, is not present in other disorders where fatigue is a predominant symptom, such as depression, rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis. 10, 11 Indeed a recent study has shown that post-exertional malaise was one of the best predictors of the differential diagnosis of chronic fatigue syndrome and major depressive disorder. 12 Success of exercise therapy in chronic fatigue syndrome most likely relates initially to its ability to demonstrate to sufferers that exercise can be safely undertaken without the consequence of post-exertional malaise, therefore assisting people with chronic fatigue syndrome to abandon any avoidance behaviours to which they may have previously adhered. 13 Thus, exercise-induced symptom exacerbations must be prevented.
In order to prevent exercise-induced symptom exacerbations, it seems plausible to use individually tailored exercise limits. There is limited evidence available supporting this notion: patients with chronic fatigue syndrome are generally able to perform light to moderate exercise (40% of peak oxygen capacity) without exacerbating their symptoms or cognitive performance. 14, 15 Still, more work in this area is required to enable clinicians to prevent post-exertional malaise when applying exercise therapy to people with chronic fatigue syndrome. The present study examined the effect of applying two methods of individually tailored exercise limits in preventing symptom increases and worsening of their health status following an exercise bout.
The first exercise limit was related to the duration of exercise and was determined by the patient's report of how long they were able to walk without increasing their symptoms. It has been suggested that people with chronic fatigue syndrome need to learn to estimate their current physical capabilities prior to commencing an exercise, 16 keeping in mind the regular fluctuating nature of their symptoms. 17, 18 In the absence of irrational fear of movement, the patient's estimated exercise duration can be reduced to account for typical overestimations made by the patient. The second exercise limit was related to the intensity of the exercise. The intensity of exercise was again calculated on an individual basis based on the results of a submaximal exercise test. The respiratory quotient reflects the quantity of carbon dioxide produced in relation to oxygen consumed. Under conditions other than steady-rate exercise, various factors can alter the exchange of oxygen and carbon dioxide in the lungs so that the respiratory quotient no longer reflects the substrate mixture in energy metabolism; the quotient is now termed the respiratory exchange ratio (RER). 19 Exhaustive exercise presents such a condition where RER can rise significantly above 1.0 due to buffering of lactic acid generation during anaerobic metabolism. 19 Heart rate recommendations derived from incremental exercise stress tests are frequently used for monitoring exercise intensity in healthy people 20 and patients with chronic fatigue syndrome. 1, 2 During the walking test in the present study, the maximum heart rate was taken to be the heart rate corresponding to RER ¼ 1.0 derived from a submaximal incremental exercise test.
It was hypothesized that by walking for a period of time determined from the subject's estimation of their exercise ability (duration) whilst at the same time maintaining a heart rate lower than the heart rate corresponding to RER ¼ 1.0 (intensity), prevents symptom increases following a walking exercise in people with chronic fatigue syndrome. Likewise, it was hypothesized that our approach to limiting exercise intensity and duration would prevent worsening of their health status up to 24 hours post-exercise.
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Methods
Design
A repeated measures semi-experimental design was used to examine the hypotheses. The local ethics committee (University Hospital Brussels; O.G. 016) approved the study protocol. During the first testing day, patients providing informed consent were asked to perform a submaximal graded bicycle ergometric test to assess the heart rate and oxygen uptake corresponding to RER ¼ 1.0, and thus to establish the maximum heart rate which would be used to limit the intensity of exercise during the walking test (as below).
The patient returned to the university at least two and maximally four weeks later to undertake the walking exercise ( Figure 1 ). On the second testing day, study participants were asked to fill in three self-reported measures, and then undertook the walking exercise with continuous heart rate monitoring. After termination of the walking exercise, the patients were given the opportunity to drink mineral water ad libidum, and were asked to fill in the same self-reported measures. Afterwards, the subjects were given a sealed envelope containing the self-reported measures and a stamped, addressed return envelope.
The subjects were instructed to fill in the questionnaires once more exactly 24 hours later and to return them to our university. Approximately 24 hours after terminating the walking exercise, subjects were contacted by telephone to ask whether their condition had improved, worsened or unchanged within the past 24 hours. In addition, they were asked whether or not they had taken additional medication to reduce symptoms, and were prompted to complete the questionnaires if they had not already done so.
Subjects
Patients with chronic fatigue syndrome were allocated from consecutive referrals to a specialized chronic fatigue clinic (sample of convenience). All participants fulfilled the Centers for Disease Control and Prevention criteria for chronic fatigue syndrome. 17 All patients underwent an extensive medical evaluation prior to study participation (for more details regarding the diagnostic strategies as applied in this study, see ref. 21) . Additional inclusion/exclusion criteria beyond the diagnostic criteria were applied: all participants had Dutch as their native language, were within the age range of 18-65 years, had to be able to walk and to perform a submaximal bicycle exercise test, and had to be willing to visit the university twice for study participation. Finally, all participants had to provide written informed consent.
Submaximal exercise stress test
Before each test, gas and volume calibration took place with a 3-1 syringe, according to the manufacturer's guidelines. The oxygen analyser was calibrated with known gas mixtures of 18% O 2 and 5% CO 2 . The room air calibration was automatically run before each test to update the CO 2 analyser baseline and the O 2 analyser gain so that they coincided with atmospheric values. The patients performed a bicycle ergometric test using a linear increase in workload. The patients sat on an electromagnetically braked ergometer (Jaeger 900; Lode B.V., Groningen, The Netherlands). Heart rate was monitored continuously during exercise using a Polar Accurex Plus (Polar Electro OY, Kempele, Finland). In order to collect pulmonary data during the test, an open circuit spirometer (Mijnhart Oxycon; IBM, Bunnik, The Netherlands) with automatic printout every 30 seconds was used. Averages were obtained for oxygen uptake and carbon dioxide production during each 30-second interval for the duration of each stage of the exercise. A two-way breathing valve attached to a mask, which covered the patients' nose and mouth, was used to collect the expired air. The air was analysed continuously for ventilatory and metabolic variables. Patients started the test at 10 W, with a linear increase of 10 W/minute. Patients were instructed to cycle at a constant speed of 60 revolutions/minute. In order to ascertain the valid collection of the physiological exercise data at RER ¼ 1.0, the test was continued until RER approached 1.1. The following variables were measured: heart rate at RER ¼ 1.0 (HR RER1 ), exercise duration, oxygen uptake at RER ¼ 1.0 (Vo 2RER1 ) per kilogram of body weight, and body weight-adjusted oxygen uptake at RER ¼ 1.0.
Walking exercise and exercise limits
Walking was chosen because it is a mode of exercise which is functionally relevant, easily applied in the clinical setting and frequently used in exercise therapy for people with chronic fatigue syndrome. 1, 2 Prior to the walking exercise, the patients were asked to indicate how long they would be able to walk on a flat surface without increasing symptoms, and whether they were currently experiencing a good or a bad day. In order to account for typical overestimations, the patient's estimated exercise duration was reduced with 25 of 50% in case of a good or a bad day respectively. This was used to limit the walking duration. In addition, the exercise intensity was limited using an upper heart rate limit corresponding to the RER ¼ 1.0 (derived from the submaximal exercise stress test). Heart rate was monitored continuously during exercise using a Polar Accurex Plus (Polar Electro OY, Kempele, Finland). The heart rate corresponding to RER ¼ 1.0 was entered in the heart rate monitor as the upper limit. The patients were asked to walk on a flat surface and in a straight line from one marking spot to another (the two marking spots were placed at a 10 m distance). The patient was instructed to walk at a steady pace, not to talk or to stop walking during the exercise, and to decrease the walking pace if the alarm went off (i.e. when the heart rate increased above the upper limit). The investigator recorded the walking distance and the number of times the alarm sounded.
Outcome measures
The Medical Outcomes Short Form 36 Health Status Survey or SF-36 assesses functional status and well-being or quality of life. 22 The SF-36 has been documented to have reliability and validity in a wide variety of patient populations [22] [23] [24] and it appears to be the most frequently used measure in chronic fatigue syndrome research. 25 The Chronic Fatigue Syndrome Symptom List is a self-reported measure for assessing symptom severity in chronic fatigue syndrome patients. It encompasses the 19 most frequently reported symptoms in a sample of 1578 chronic fatigue syndrome patients. 26 In order to assess the severity of the symptoms included in the Chronic Fatigue Syndrome Symptom List, visual analogue scales (100 mm) are used. In a previous study in 68 chronic fatigue syndrome patients, the internal consistency of the different items included in the Dutch Chronic Fatigue Syndrome Symptom List was high (Cronbach's a ¼ 0.88). 27 The Chronic Fatigue Syndrome Symptom List displayed excellent test-retest reliability (ICC ! 0.97), content and concurrent validity (manuscript in review).
The Chronic Fatigue Syndrome -Activities and Participation Questionnaire or CFS-APQ is a selfadministered questionnaire aimed at monitoring activity limitations and participation restrictions in patients with chronic fatigue syndrome. A total score of 1 indicates no activity limitations or participation restrictions while 16 represents the maximum score. Data documenting the test-retest reliability, internal consistency, content, convergent and discriminant validity of the Dutch CFS-APQ in chronic fatigue syndrome patients have been reported. 28, 29 
Data analysis
All data were analysed using SPSS 14.0 for Windows (SPSS Inc., Chicago, IL, USA). The sample size was determined on the basis of the post-hoc power analysis performed after analysing the data of the first 11 subjects completing the study. The data of the 11 subjects were analysed for potential pre-versus post-exercise differences using a Friedman two-way analysis of variances and subsequent post-hoc power analysis, revealing that at least 22 subjects were required to obtain a Power (1 -b) of 0.80. For analysing the data of the entire study sample (n ¼ 24), a one-sample Kolmogorov-Smirnov goodness-of-fit test was used to examine whether the variables were normally distributed. In case of normality, potential differences between the first, second and third assessment were examined using repeated measures analysis of variances and post-hoc paired samples t-testing. Variables that were not normally distributed were analysed using the non-parametric Friedman two-way analysis of variances for three related samples. In order to account for missing data, the 'last observation carried forward method' was used for intentionto-treat analysis. The level of significance was set at 0.05. Effect sizes of the SF-36 subscale scores were counted and interpret according to method described in ref. 30 .
Results
The mean age of the study participants (n ¼ 24) was 37.6 AE 9. The physiological data obtained during the submaximal exercise stress test are presented in Table 1 . Of particular interest is the heart rate corresponding to RER ¼ 1.0, which was used to limit the walking exercise during the second testing day. On the day of the walking exercise, only 9 of 24 participants (37%) were experiencing a good day. During the exercise bout, the heart rate of the majority of participants (19/24 or 79%) remained below their heart rate limit (i.e. the heart rate corresponding to RER ¼ 1.0). In five cases, the heart rate alarm went off at least once (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] ) during the exercise bout, forcing them to decrease their walking speed. The performance data of the walking exercise are presented in Table 2 .
The comparisons between the pre-versus post-exercise symptom severity and health status scores are presented in Table 3 . One participant failed to return the 24 hours post-exercise questionnaires, leaving us with only pre-exercise and immediately post-exercise questionnaires for that participant. The 'last observation carried forward method' was used as intention-to-treat analysis, but this did not alter the results presented below (data not shown). There was no change in self-reported activity limitations/participation restrictions or total scores on the Chronic Fatigue Syndrome Symptom List between the three assessments (pre-exercise, immediately and 24 hours post-exercise). However, fatigue and musculoskeletal pain worsened in response to the walking exercise. The fatigue increase observed immediately post-exercise (t ¼ À3.0; P ¼ 0.006) improved in the next 24 hours and no longer differed from the pre-exercise scores at 24 hours post-exercise (t ¼ À1.9; P ¼ 0.07). The increase in musculoskeletal pain observed immediately post-exercise (t ¼ À3.7; P ¼ 0.001) was retained at 24 hours post-exercise (t ¼ À2.3; P ¼ 0.03). Likewise, the bodily pain subscale score of the SF-36 worsened from pre-to post-exercise (t ¼ 2.5; P ¼ 0.02), and this situation remained at 24 hours post-exercise (t ¼ 2.9; P ¼ 0.009). Effect sizes of the SF-36 subscale scores were counted and interpreted according to the method described in ref. 30 . Fourteen of 24 subjects experienced a clinically meaningful change in bodily pain (i.e. a minimum change of the SF-36 bodily pain subscale score of 10). Apart from the symptom 'sore throat', no other symptoms included in the Chronic Fatigue Syndrome Symptom List changed in response to the walking exercise (data not shown). The severity in sore throat increased from pre-to 24 hours post-exercise (t ¼ À3.5; P ¼ 0.002), but this change was largely due to the increase from immediately post-exercise to 24 hours post-exercise (t ¼ À2.7; P ¼ 0.01), and not due to a change from pre-to immediately post-exercise (t ¼ À1.8; P ¼ 0.09). At 24 hours post-exercise, the majority of participants (18/24 or 75%) reported that their health status had not changed within the past 24 hours, and the remaining participants (6/24) indicated that the exercise bout had slightly worsened their health status. None of the participants had taken additional medication to relieve the worsening of their health status. Analysing the mean SF-36 subscale scores over time, general health perception, physical functioning, social functioning, mental health, role limitations due to emotional problems or due to physical functioning did not change in response to the walking exercise. Although a decrease in vitality was observed both immediately (t ¼ 2.2; P ¼ 0.04) and 24 hours postexercise (t ¼ 2.8; P ¼ 0.01), 2 of the 24 patients had a clinically meaningful change in vitality (i.e. a minimum change of the SF-36 vitality subscale score of 20 30 ).
Discussion
It was shown that the use of exercise limits (limiting both the intensity and duration of exercise) prevents important health status changes following a walking exercise in people with chronic fatigue syndrome, but was unable to prevent short-term symptom increases. Although the mean total score on the Chronic Fatigue Syndrome Symptom List did not change in response to the exercise bout, an acute increase in fatigue and musculoskeletal pain was observed. Fatigue severity returned to its pre-exercise level at 24 hours post-exercise, but the worsening of musculoskeletal pain was still evident at 24 hours post-exercise. The majority of subjects (58%) experienced a clinically meaningful increase in bodily pain. In addition, sore throat severity was increased at 24 hours post-exercise. Experiencing a sore throat in response to exercise has previously been reported in people with chronic fatigue syndrome. 6, 14 Thus, it seems the walking exercise triggered a short-term increase in fatigue and worsening of musculoskeletal pain for at least 24 hours post-exercise. Still, given the short-term effects on fatigue and the limited (approximately 10% on a visual analogue scale) increase in musculoskeletal pain, the exercise bout did not trigger severe post-exertional malaise but a limited symptom increase. This conclusion is further supported by the fact that no participant needed to use medication post-exercise to account for their symptom increase. The short-term effects on fatigue as observed here, together with the previous report of fatigue increase up to 12 days (mean 8.8 days) after a maximal exercise bout, 6 suggests that exercise limits can limit post-exertional increase in fatigue. In summary, the use of the heart rate corresponding to RER ¼ 1.0, together with the self-paced exercise duration did not completely prevent symptom increases following a walking exercise, but did not trigger severe malaise either. In addition, it was hypothesized that our approach to limiting exercise intensity and duration would prevent worsening of the patients' health status post-exercise. Our data are partly in support of this hypothesis: the walking exercise did not alter activity limitations/participation restrictions, general health perception, physical functioning, role limitations due to emotional problems, mental health, social functioning, or role limitations due to physical functioning. On the other hand, 25% of the participants reported at 24 hours post-exercise that the exercise bout had slightly worsened their health status, and a slight decrease in vitality was observed up to 24 hours post-exercise. Only a small proportion of the patients (8%) had a clinically meaningful decrease in vitality, questioning the clinical importance of the observed statistically significant change in vitality. It is concluded that the present approach of limiting exercise intensity does not completely prevent worsening of health status in all people with chronic fatigue syndrome, but it does not trigger important changes in health status either. These data in relation to both symptom and health status changes in response to a paced walking exercise highlight the fact that physiotherapists and rehabilitation specialists should be cautious when using exercise in people with chronic fatigue syndrome. However the results for a minority of the subjects studied here support the notion that the exercise intensity necessary to cause a symptom increase can be quite mild. 31 The present approach to exercise may be useful in preventing important changes in health status of people with chronic fatigue syndrome, but further studying of the ability of other exercise limits to prevent worsening of symptoms and health status in response to exercise in people with chronic fatigue syndrome is warranted. In this regard, it might be useful to consider that 63% of our subjects were only walking for 50% of the time they estimated they could walk, supporting the anecdotal evidence of typical overestimations in people with chronic fatigue syndrome.
Our results are consistent with those reported by Clapp et al. 14 who studied the acute effects of 10 discontinuous 3-minute exercise bouts on a treadmill in 10 patients with chronic fatigue syndrome. There was a 3-minute recovery period between exercise bouts, and the participants walked at a comfortable walking pace self-selected by the subjects, as was the case in our study. On average, their subjects walked at a speed of 0.71 AE 0.20 m/s, which is slightly lower than that in our subjects (0.9 AE 0.2 m/s). The results were in line with our findings: it was found that the symptoms did not worsen severely after exercise, but some patients reported experiencing headaches, leg pain, fatigue or sore throats. As was the case in our study, there was no change in the degree of disability or general health status. Others used a maximal bicycle exercise stress test to determine the submaximal exercise intensity (40% of peak oxygen uptake) for a 25-minute exercise bout approximately two weeks later. 15 Analysing the group data, the exercise bout had no effect on tiredness, energy or cognitive performance. In our study, submaximal exercise testing was chosen to determine exercise intensity because it is unlikely in itself to cause significant increase in symptoms as may occur following peak exercise testing, 32 making it difficult to compare our results to the ones reported by Cook et al. 15 Still, the use of the heart rate corresponding to RER ¼ 1.0 was chosen as a non-invasive, indirect way of achieving aerobic exercise. It has previously been shown that 15 minutes of subanaerobic (at 90% of their predicted work rate at their anaerobic threshold) bicycle exercise did not exacerbate gait parameters in people with chronic fatigue syndrome. 33 Since direct monitoring of the physiological exercise response during the walking test was not performed, we are unable to state that the walking exercise was performed at an aerobic level. The use of the heart rate corresponding to RER ¼ 1.0 as an exercise limit is likely to prevent anaerobic exercise, even in people with chronic fatigue syndrome.
Addressing the study limitations, the lack of additional physiological monitoring during the walking exercise has been mentioned. On the other hand, use of physiological measurements during exercise is unlikely to reflect a clinical approach to exercise in people with chronic fatigue syndrome. In addition, the concept of postexertional malaise requires an objective definition with one or more cut-off criteria. In this view, a control group not performing any exercise throughout the trial would have strengthened the study, especially given the fluctuating nature of the illness. On the other hand, since even routine daily activities such as ironing frequently trigger symptom increases, it would be extremely difficult to ascertain no 'damaging' physical activity in the untreated control group. The latter issue applies to the 24 hours post-exercise assessment of the present study as well: the observed changes at 24 hours post-exercise might not be related to the walking exercise, but instead triggered by other physical demanding activities. The symptom and health status changes observed immediately post-exercise are unlikely to be biased: the study participants had no opportunity to do anything else besides the walking exercise between the first and the second assessment. Another study limitation addresses the external validity of the results: as is the case in many, if not all studies on exercise in chronic fatigue syndrome, the results can only be extrapolated to those having at least some training load. Finally, it is unclear whether the level of exercise which was undertaken would be sufficient to improve cardiovascular fitness and reduce deconditioning. More work is required to address the issue of prevention of post-exertional malaise in people with chronic fatigue syndrome, for instance by using exercise limits as previously used in randomized controlled clinical trials of exercise therapy in people with chronic fatigue syndrome (e.g. exercise intensity based on the heart rate value obtained midpoint during a submaximal exercise test 2 or the heart rate corresponding to 40% of peak oxygen consumption during a maximal exercise test 1 ).
In conclusion, it was shown that the use of the heart rate corresponding to RER ¼ 1.0, together with the self-paced exercise duration, resulted in a short-term worsening of fatigue and an increase in pain up to 24 hours post-exercise. The concomitant use of two exercise limits did prevent health status changes following a walking exercise in people with chronic fatigue syndrome. Thus, the present data suggest that exercise limits can prevent post-exertional malaise, but cannot prevent an acute symptom increase postexercise in people with chronic fatigue syndrome.
Future studies could address the study limitations of the present study to examine the ability of other exercise limits to prevent worsening of symptoms and health status in response to exercise in people with chronic fatigue syndrome.
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